Your Article Summary
MediGene Spins Out mTCR Programme - Independent Company Immunocore Limited Founded
MediGene, 10/06/08
MediGene AG and three private investors have founded Immunocore Ltd, which will focus on the technology platform for monoclonal T-cell receptors (mTCR) of MediGene's UK subsidiary MediGene Ltd. MediGene holds a 38.5% stake in Immunocore Ltd and will be the largest shareholder of the new company.
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
Position statement of the Portuguese Society of Nephrology on the clinical use of biotechnological drugs in renal patients
Portuguese Journal of Nephrology and Hypertension, 10/12/09
Orally Disintegrating Tablets: The Effect of Recent FDA Guidance on ODT Technologies and Applications
Pharmaceutical Technology, 10/14/09
Cardiac Cell Repair Therapy: A Clinical Perspective
Mayo Clinic Proceedings, 10/12/09
Article Search
Sponsor


See Latest Articles


